دورية أكاديمية
Folic acid supplementation during pregnancy and postpartum depressive symptoms ; Suplementação de ácido fólico na gestação e sintomas depressivos pós-parto
| العنوان: | Folic acid supplementation during pregnancy and postpartum depressive symptoms ; Suplementação de ácido fólico na gestação e sintomas depressivos pós-parto |
|---|---|
| المؤلفون: | Lutz, Bárbara Heather, Santos, Iná da Silva dos, Domingues, Marlos Rodrigues, Murray, Joseph, Silveira, Mariângela Freitas da, Miranda, Vanessa Irribarem Avena, Silveira, Marysabel Pinto Telis, Mengue, Sotero Serrate, Pizzol, Tatiane da Silva dal, Bertoldi, Andréa Dâmaso |
| المصدر: | Revista de Saúde Pública; Vol. 57 No. 1 (2023); 76 ; Revista de Saúde Pública; Vol. 57 Núm. 1 (2023); 76 ; Revista de Saúde Pública; v. 57 n. 1 (2023); 76 ; 1518-8787 ; 0034-8910 |
| بيانات النشر: | Universidade de São Paulo. Faculdade de Saúde Pública |
| سنة النشر: | 2023 |
| المجموعة: | Universidade de São Paulo: Portal de Revistas da USP |
| مصطلحات موضوعية: | Pregnancy, Folic Acid, Depression, Postpartum, Cohort Studies, Gravidez, Ácido Fólico, Depressão Pós-Parto, Estudos de Coortes |
| الوصف: | OBJECTIVE: To verify whether folic acid supplementation during pregnancy is associated with the occurrence of maternal depressive symptoms at three months postpartum, in the 2015 Pelotas Birth Cohort. METHODS: This study included 4,046 women, who were classified into three groups: did not use folic acid supplementation during pregnancy; used during only one trimester of pregnancy; and used for two or three trimesters. Depressive symptoms were assessed at three months postpartum using the Edinburgh Postnatal Depression Scale (EPDS), at cutoff points ≥ 10 (mild symptoms) and ≥ 13 (moderate to severe intensity). RESULTS: The overall prevalence of mild symptoms was of 20.2% (95%CI 19.0–21.5), and moderate and severe was 11% (95%CI 10.0–12.0). The prevalence of EPDS ≥ 10 was of 26.8% (95%CI 24.0–29.5) among women who did not use folic acid and 18.1% for both those who used it during one trimester of pregnancy (95%CI 16.1–20.1) and those who used it for two or three trimesters (95%CI 16.0–20.2). The prevalence of EPDS ≥ 13 was of 15.7% (95%CI 13.5–17.9) in those who did not use folic acid, 9.1% (95%CI 7.5–10.6) in those who used it for one trimester, and 9.4% (95%CI 7.8–11.0) in those who used it for two or three trimesters. In the adjusted analyses, there was no statistically significant association between the use of folic acid during pregnancy and the occurrence of depressive symptoms at three months postpartum. CONCLUSION: Th ere w as n o a ssociation b etween f olic a cid s upplementation d uring pregnancy and postpartum depression at three months. ; OBJETIVO: Verificar se a suplementação de ácido fólico durante a gestação está associada com a ocorrência de sintomas depressivos maternos aos três meses pós-parto, na Coorte de Nascimentos de Pelotas de 2015. MÉTODOS: Este estudo incluiu 4.046 mulheres, que foram classificadas em três grupos: sem suplementação de ácido fólico na gestação; uso durante apenas um trimestre da gestação; e uso durante dois ou três trimestres. Os sintomas depressivos foram avaliados aos ... |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | application/pdf; text/xml |
| اللغة: | Portuguese English |
| العلاقة: | https://www.revistas.usp.br/rsp/article/view/219813/200679Test; https://www.revistas.usp.br/rsp/article/view/219813/200678Test; https://www.revistas.usp.br/rsp/article/view/219813/200677Test; https://www.revistas.usp.br/rsp/article/view/219813Test |
| الإتاحة: | https://www.revistas.usp.br/rsp/article/view/219813Test |
| حقوق: | Copyright (c) 2023 Bárbara Heather Lutz, Iná da Silva dos Santos, Marlos Rodrigues Domingues, Joseph Murray, Mariângela Freitas da Silveira, Vanessa Irribarem Avena Miranda, Marysabel Pinto Telis Silveira, Sotero Serrate Mengue, Tatiane da Silva dal Pizzol, Andréa Dâmaso Bertoldi ; https://creativecommons.org/licenses/by/4.0Test |
| رقم الانضمام: | edsbas.DFA19A81 |
| قاعدة البيانات: | BASE |
| الوصف غير متاح. |